CSL Research Acceleration Initiative

Image for CSL Research Acceleration Initiative

Deadline: 27th February 2024

CSL is a leading global biotech company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives. CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations.

Successful applicants will receive funding of up to $400,000 USD over 2 years.

Interested researchers are invited to:

·        Attend information webinars to learn more about the initiative:

              23rd January 10:00 GMT OR 24th January 16:00 GMT

·        Contact Meghana Patel ( and Anita Marguerie de Rotrou ( to express interest in applying and to obtain online application submission instructions.

·        Submit a non-confidential, 300-word abstract via the CSL online application portal by 27th February 2024.

Posted on 23/01/2024